CDKN2A and melanoma: Furthermore, the objectives include the correlation between the CDKN2A tumoral status and clinic-pathological melanoma characteristics (such as anatomical site, histopathological subtype, Breslow index, mitotic rate, etc.)and the possibility of using CDKN2A variations as potential prognostic markers in melanoma.